Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme-Reference-Cited by-同舟云学术

Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme

Published:2002-02-28 Issue:3 Volume:15 Page:233-240
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J. Magn. Reson. Imaging

Author:

Gossmann Axel,Helbich Thomas H.,Kuriyama Nagato,Ostrowitzki S.,Roberts Timothy P.L.,Shames David M.,van Bruggen N.,Wendland Michael F.,Israel Mark A.,Brasch Robert C.

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging

Reference31 articles.

1. Brain Tumors

2. Angiogenesis in malignant gliomas

3. Vascular endothelial growth factor: basic biology and clinical implications. In: editor. EXS. Basel: Birkhauser Verlag; 1997. p 209-232.

4. Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Image-based predictive modelling frameworks for personalised drug delivery in cancer therapy;Journal of Controlled Release;2024-06

2. Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma;Cancers;2024-05-11

3. Therapeutic targeting of angiopoietins in tumor angiogenesis and cancer development;Biochemical and Biophysical Research Communications;2023-12

4. Perfusion magnetic resonance imaging for brain tumour characterisation and assessment of treatment response;Handbook of Neuro-Oncology Neuroimaging;2022

5. Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets;Frontiers in Oncology;2019-09-26